Skip to main navigation Skip to search Skip to main content
2   Link opens in a new tab Citations (SciVal)

Abstract

This study identifies biochemical markers (BCIs) that can be used as population markers in wastewater-based epidemiology (WBE) and compares their estimates with other established population size estimation (PE) methods, including census data (PECEN). Several groups of BCIs (64 targets: genetic and chemical markers) were investigated in an intercity study, including 10 cities/towns within England equating to a population of ∼7 million people. Several selection criteria were applied to identify the best BCIs to provide robust estimation of population size at a catchment level: (1) excellent performance with analytical methods; (2) excellent fit of the linear regression model which indicates PE-driven BCI daily loads; (3) low temporal variability in usage; (4) human-linked origin. Only a few tested BCIs showed a strong positive linear correlation between daily BCI loads and PE indicating their low spatiotemporal variability. These are: cimetidine, clarithromycin, metformin, cotinine, bezafibrate, metronidazole and hydroxymetronidazole, diclofenac, and benzophenone 1. However, only high/long term usage pharmaceuticals: cimetidine and metformin as well as cotinine (metabolite of nicotine) performed well when tested in two independent datasets and catchments accounting for both spatial and temporal scales. Strong seasonal usage trends were observed for antihistamines, NSAIDs (anti-inflammatories), antibiotics and UV filters, invalidating them as PE markers. Key conclusions from the study are: (1) Cimetidine is the best performing BCI; (2) Chemical markers outperform genetic markers as PE BCIs; (3) Water utility PE estimates (PEWW) align well with PECEN and PEBCI values; (4) Ammonium/orthophosphate as well as viral PE markers suffer from high temporal variability, hence, they are not recommended as PEBCI markers, and, most importantly, (5) PEBCI calibration/validation at the country/region level is advised in order to establish the best PE markers suited for local/national needs and accounting for site/region specific uncertainties.

Original languageEnglish
Article number122527
Number of pages15
JournalWater Research
Volume268
Issue numberPart A
Early online date9 Oct 2024
DOIs
Publication statusPublished - 1 Jan 2025

Data Availability Statement

The relevant data is available in SI.

Acknowledgements

We thank Daphne Beniston and Andrew Singer (Accelerated Capability Environment, Homeland Security, UK) for their help organising the project. We thank Public Health Wales for providing enterovirus primer and probe sequences and the staff at Anglian Water, Northumbrian Water, Southern Water, Thames Water, United Utilities and Yorkshire Water for their support with wastewater sampling. The support of EPSRC Impact Acceleration Account (EP/R51164X/1, ENTRUST IAA) and GCRF EWS-C19 (EP/V028499/1) is greatly appreciated.

Funding

The work was supported under the C215.3 Wastewater Based Epidemiology Programme within the UK Government Accelerated Capability Environment (ACE), funded by the Environmental Monitoring for Health Protection (EMHP) programme, UK Health Security Agency

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chemical and viral biomarkers
  • Pharmaceuticals
  • Population size estimation (PE)
  • Public health surveillance
  • Viruses
  • Wastewater-based epidemiology
  • WBE

ASJC Scopus subject areas

  • Environmental Engineering
  • Civil and Structural Engineering
  • Ecological Modelling
  • Water Science and Technology
  • Waste Management and Disposal
  • Pollution

Fingerprint

Dive into the research topics of 'Multi-biomarker approach for estimating population size in a national-scale wastewater-based epidemiology study'. Together they form a unique fingerprint.

Cite this